$362.30
1.64% yesterday
NYSE, May 15, 10:14 pm CET
ISIN
US92826C8394
Symbol
V

Visa Target price 2025 - Analyst rating & recommendation

Visa Classifications & Recommendation:

Buy
79%
Hold
21%

Visa Price Target

Target Price $382.48
Price $362.30
Potential 5.57%
Number of Estimates 36
36 Analysts have issued a price target Visa 2026 . The average Visa target price is $382.48. This is 5.57% higher than the current stock price. The highest price target is $440.00 21.45% , the lowest is $305.00 15.82% .
A rating was issued by 43 analysts: 34 Analysts recommend Visa to buy, 9 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Visa stock has an average upside potential 2026 of 5.57% . Most analysts recommend the Visa stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2028


Sep '24 2025
Estimates
Revenue Billion $ 35.93 39.51
10.02% 9.98%
EBITDA Margin 70.13% 70.70%
0.26% 0.81%
Net Margin 51.86% 52.96%
6.95% 2.11%

35 Analysts have issued a sales forecast Visa 2025 . The average Visa sales estimate is $39.5b . This is 5.03% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $40.0b 6.32% , the lowest is $39.1b 3.80% .

This results in the following potential growth metrics:

Revenue Estimates

2024 $35.9b 10.02%
2025 $39.5b 9.98%
2026 $43.7b 10.48%
2027 $47.9b 9.67%
2028 $52.5b 9.62%

20 Analysts have issued an Visa EBITDA forecast 2025. The average Visa EBITDA estimate is $27.9b . This is 5.51% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $28.9b 9.01% , the lowest is $27.3b 3.29% .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $25.2b 9.73%
2025 $27.9b 10.87%
2026 $30.8b 10.35%
2027 $33.9b 9.96%
2028 $37.1b 9.35%

EBITDA Margin

2024 70.13% 0.26%
2025 70.70% 0.81%
2026 70.61% 0.13%
2027 70.79% 0.25%
2028 70.62% 0.24%

23 Visa Analysts have issued a net profit forecast 2025. The average Visa net profit estimate is $20.9b . This is 9.57% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $22.0b 15.36% , the lowest is $20.4b 6.61% .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $18.6b 17.67%
2025 $20.9b 12.31%
2026 $24.6b 17.55%
2027 $27.8b 13.00%
2028 $31.0b 11.42%

Net Margin

2024 51.86% 6.95%
2025 52.96% 2.11%
2026 56.35% 6.40%
2027 58.06% 3.03%
2028 59.02% 1.65%

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028


Sep '24 2025
Estimates
Earnings Per Share $ 9.59 10.77
17.67% 12.30%
P/E 33.64
EV/Sales 17.88

23 Analysts have issued a Visa forecast for earnings per share. The average Visa EPS is $10.77 . This is 9.56% higher than earnings per share in the financial year 2024. The highest EPS forecast is $11.34 15.36% , the lowest is $10.48 6.61% .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $9.59 17.67%
2025 $10.77 12.30%
2026 $12.66 17.55%
2027 $14.31 13.03%
2028 $15.94 11.39%

P/E ratio

Current 36.85 15.59%
2025 33.64 8.71%
2026 28.62 14.92%
2027 25.32 11.53%
2028 22.73 10.23%

Based on analysts' sales estimates for 2025, the Visa stock is valued at an EV/Sales of 17.88 and an P/S ratio of 17.78 .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 18.78 13.75%
2025 17.88 4.78%
2026 16.19 9.49%
2027 14.76 8.82%
2028 13.46 8.77%

P/S ratio

Current 18.67 13.50%
2025 17.78 4.79%
2026 16.09 9.49%
2027 14.67 8.82%
2028 13.39 8.77%

Current Visa Upgrades & Downgrades

Analyst Rating Action Date
UBS
Buy
Buy
Unchanged Apr 30 2025
Macquarie
Outperform
Outperform
Unchanged Apr 30 2025
Piper Sandler
Overweight
Overweight
Unchanged Apr 30 2025
BMO Capital
Outperform
Outperform
Unchanged Apr 30 2025
Evercore ISI Group
In-Line
Initiated Apr 09 2025
Susquehanna
Positive
Positive
Unchanged Feb 21 2025
Barclays
Overweight
Overweight
Unchanged Feb 03 2025
Analyst Rating Date
Unchanged
UBS:
Buy
Buy
Apr 30 2025
Unchanged
Macquarie:
Outperform
Outperform
Apr 30 2025
Unchanged
Piper Sandler:
Overweight
Overweight
Apr 30 2025
Unchanged
BMO Capital:
Outperform
Outperform
Apr 30 2025
Initiated
Evercore ISI Group:
In-Line
Apr 09 2025
Unchanged
Susquehanna:
Positive
Positive
Feb 21 2025
Unchanged
Barclays:
Overweight
Overweight
Feb 03 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today